vTv Therapeutics, Inc. (VTVT)
31.18
+1.10
(+3.66%)
USD |
NASDAQ |
Oct 09, 16:00
31.06
-0.12
(-0.37%)
After-Hours: 20:00
vTv Therapeutics Price to Book Value : 1.562 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 1.562 |
| October 08, 2026 | 1.507 |
| October 07, 2026 | 1.553 |
| October 06, 2026 | 1.504 |
| October 05, 2026 | 1.519 |
| October 02, 2026 | 1.531 |
| October 01, 2026 | 1.595 |
| September 30, 2026 | 1.545 |
| September 29, 2026 | 1.503 |
| September 28, 2026 | 1.529 |
| September 25, 2026 | 1.513 |
| September 24, 2026 | 1.539 |
| September 23, 2026 | 1.532 |
| September 22, 2026 | 1.558 |
| September 21, 2026 | 1.568 |
| September 18, 2026 | 1.593 |
| September 17, 2026 | 1.573 |
| September 16, 2026 | 1.526 |
| September 15, 2026 | 1.526 |
| September 14, 2026 | 1.575 |
| September 11, 2026 | 1.601 |
| September 10, 2026 | 1.596 |
| September 09, 2026 | 1.668 |
| September 08, 2026 | 1.642 |
| September 04, 2026 | 1.671 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.677 |
| September 02, 2026 | 1.673 |
| September 01, 2026 | 1.600 |
| August 31, 2026 | 1.603 |
| August 28, 2026 | 1.621 |
| August 27, 2026 | 1.643 |
| August 26, 2026 | 1.682 |
| August 25, 2026 | 1.699 |
| August 24, 2026 | 1.698 |
| August 21, 2026 | 1.666 |
| August 20, 2026 | 1.657 |
| August 19, 2026 | 1.648 |
| August 18, 2026 | 1.577 |
| August 17, 2026 | 1.568 |
| August 14, 2026 | 1.509 |
| August 13, 2026 | 1.545 |
| August 12, 2026 | 1.592 |
| August 11, 2026 | 1.655 |
| August 10, 2026 | 1.718 |
| August 07, 2026 | 1.772 |
| August 06, 2026 | 1.734 |
| August 05, 2026 | 1.723 |
| August 04, 2026 | 1.606 |
| August 03, 2026 | 1.622 |
| July 31, 2026 | 1.620 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.98 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.034 |
| Vericel Corp. | 5.545 |
Price to Book Value Related Metrics
| PS Ratio | 10.05 |
| Price | 31.18 |
| Earnings Yield | -3.39% |
| Market Cap | 122.81M |